Oral Cancer Test Gets European Conformity (CE) Mark
Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer RAPID Test, enabling the company to market the product.
Industry News
Cancer Detection Tool Earns CE Mark
The OncAlert Oral Cancer CD44/Total Protein LAB Test from Vigilant Biosciences now has the CE Mark, which means it has been approved for.
- November 18, 2015
- 1 minute read
